Middle-income countries’ healthcare sectors to keep rising through to 2024
Healthcare provision markets of middle-income countries are set to climb at an average annual rate of 5.7% in the next three years.
Molnupiravir: Merck’s Covid-19 antiviral less effective in new analysis
Updated data on molnupiravir shows the drug reduces hospitalisation or death by 30%, down from...
EMA recommends Pfizer-BioNTech’s Covid-19 vaccine for children
The EC will review the CHMP's guidance and decide whether to update the vaccine's conditional marketing authorisation.
Biomanufacturers are facing persistent malware attacks, says cybersecurity group
The cyberattack, named Tardigrade, has been identified at two different biomanufacturing facilities.
Digitising the pharma supply chain
The Covid-19 pandemic has highlighted the need for security and traceability at every step of the drug supply chain.
Latest Deals
-
Marathon Asset ManagementMergers & Acquisitions $310M
-
Link HealthLicensing Agreement $67.83M
-
AztiqMergers & Acquisitions $475M
-
Twist BioscienceMergers & Acquisitions $190M
-
Marathon Asset ManagementMergers & Acquisitions $310M
-
Link HealthLicensing Agreement $67.83M
-
AztiqMergers & Acquisitions $475M
-
Twist BioscienceMergers & Acquisitions $190M
Weekly chart
Top countries for AI jobs growth in pharmaceutical in the three months to September
Source: GlobalData
| Country | July-Sept YoY AI jobs growth (%) |
|---|---|
| United States | 4.2 |
| China | 2.1 |
| Poland | 1.9 |
| France | 1.3 |
| India | 0.6 |
| Germany | 0.4 |
Latest News
Marathon Asset Management to acquire pharmaceutical firm Kaléo for $310m
Kaléo currently markets the AUVI-Q 0.15mg and 0.3mg, as well as the AUVI-q 0.1mg injections.
EC grants approval for Merck-Eisai’s combo therapy for endometrial cancer
The approval is based on positive data from the Phase III KEYNOTE-775/Study 309 trial of Keytruda plus Lenvima.
Omicron variant minimally impacts Gritstone’s Covid-19 vaccines
Only 2% of the 146 non-Spike TCEs given within the vaccine currently in trials in the UK and US were affected by Omicron.Â
Link Health to obtain global rights for Bone Therapeutics’ cell therapy
The new agreement is in addition to the deal entered last year to develop and market ALLOB.
Latest Themes
BYJU’s, India’s most valuable unicorn, is giving the UK an education in AI technology
Byju’s expansion comes to the UK with an innovation hub exploring AI technology in education.
Filings buzz in pharmaceuticals: 25% increase in robotics mentions since Q2 2020
The frequency of sentences related to robotics between July 2020 and June 2021 was 50% higher than in 2016.
Digital media hiring levels in the pharmaceutical industry dropped in October 2021
40% of the companies included in our analysis recruited for at least one digital media position.
Paxlovid: what we know about Pfizer’s Covid-19 pill
Pfizer is seeking emergency use authorisation from the FDA for its novel Covid-19 antiviral pill Paxlovid.
Cold Wars in the AI Summer: Automation is heating up cyber defence
AI can help forces in the defence of their systems – and offense upon others. But how far ahead are Russia and China?
Robotics-related deals in the pharmaceutical industry increased in H1 2021
Robotics-related deals made up 0.6% of all deals announced in the pharma sector in H1 2021.
Handling consent across different data channels in healthcare
Dealing with consent throughout multiple data channels within healthcare is a complex issue that can even delay treatment for patients. Organisations seeking consent also need to be fully aware of restrictions and regulations in data management. Syrenis CEO Glenn Jackson explains more about the issue of consent in healthcare and how Cassie, the company’s consent and preference management platform, can help.
Amazon Care lands largest customer yet in hotel chain Hilton
Amazon Care, the ecommerce giant’s healthcare business, has signed a deal with Hilton to provide its staff with on-demand virtual medical services.
Expert Commentary & Analysis
View MoreIvermectin use for Covid-19 treatment is not indicated nor approved by the FDA
Data for ivermectin's therapeutic effectiveness for treating Covid-19 have been questionable, with several studies deemed...
Mixed results from use of artificial intelligence in helping combat Covid-19
Many artificial intelligence tools have been developed in response to the Covid-19 pandemic, but their...
Acute glass bottle shortage threatens US spirits sales – leading macroeconomic influencers
A strong alcohol demand and Covid-19 vial competition has left American distillers looking for new...
US inflation becomes a political pawn – leading macroeconomic influencers
Republicans target Biden and Democrats over inflation, calling it a political gold mine to overthrow...